Labetalol hydrochloride

CAS No. 32780-64-6

Labetalol hydrochloride ( AH 5158A; Normodyne; NSC 290312; SCH 15719W; Trandate )

Catalog No. M14067 CAS No. 32780-64-6

Labetalol hydrochloride is a mixed alpha/beta adrenergic antagonist that is used to treat high blood pressure.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 35 In Stock
100MG 47 In Stock
200MG 65 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Labetalol hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Labetalol hydrochloride is a mixed alpha/beta adrenergic antagonist that is used to treat high blood pressure.
  • Description
    Labetalol hydrochloride is a mixed alpha/beta adrenergic antagonist that is used to treat high blood pressure.
  • Synonyms
    AH 5158A; Normodyne; NSC 290312; SCH 15719W; Trandate
  • Pathway
    Endocrinology/Hormones
  • Target
    Adrenergic Receptor
  • Recptor
    α1-adrenergic receptor
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    32780-64-6
  • Formula Weight
    364.87
  • Molecular Formula
    C19H25ClN2O3
  • Purity
    >98%(HPLC)
  • Solubility
    Ethanol: 7 mg/mL (19.18 mM); Water: 8 mg/mL (21.92 mM); DMSO: 72 mg/mL (197.33 mM)
  • SMILES
    Cl.CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Riva E, et al. Br J Pharmacol. 1991 Dec;104(4):823-8.
molnova catalog
related products
  • Formoterol

    Formoterol is a novel highly β2-selective adrenergic agonist and holds promise as a β2-agonist that could impart selective beneficial metabolic effects.

  • Moxisylyte hydrochlo...

    An alpha-adrenergic blocking agent that is used in Raynaud's disease.

  • Celiprolol hydrochlo...

    A cardioselective beta-1 adrenergic antagonist that has intrinsic symopathomimetic activity.